Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Mason

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Scandinavian Journal of Rheumatology|June 30, 2025
Genetically predicted serum urate and cancer risk: a Mendelian randomization studyT Fatima, M Dehlin, S Burgess, et al.
Journal of Medicinal Chemistry|November 23, 2000
Design and synthesis of pyrrolidine-5,5-trans-lactams (5-oxo-hexahydro-pyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 1. The alpha-methyl-trans-lactam templateA D Borthwick, S J Angier, A J Crame, et al.
Nucleosides & Nucleotides|March 6, 1999
The synthesis and antiviral activity of 4-fluoro-1-beta-D-ribofuranosyl-1H-pyrazole-3-carboxamideR Storer, C J Ashton, A D Baxter, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Scandinavian Journal of Rheumatology|June 30, 2025
Genetically predicted serum urate and cancer risk: a Mendelian randomization studyT Fatima, M Dehlin, S Burgess, et al.
Journal of Medicinal Chemistry|November 23, 2000
Design and synthesis of pyrrolidine-5,5-trans-lactams (5-oxo-hexahydro-pyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 1. The alpha-methyl-trans-lactam templateA D Borthwick, S J Angier, A J Crame, et al.
Nucleosides & Nucleotides|March 6, 1999
The synthesis and antiviral activity of 4-fluoro-1-beta-D-ribofuranosyl-1H-pyrazole-3-carboxamideR Storer, C J Ashton, A D Baxter, et al.
Pageof 3